OUR VISION

Making a difference

Cancer, a disease that is all too often unforgiving, has a profound impact on the lives of not only patients, but their loved ones. Mutual assistance and empathy are central to our values. With this in mind, our team works to push back the limits of therapeutic innovation to give people hope for better days to come.

OUR MISSION

Giving patients a second chance

We intend to bring new, effective therapeutic solutions to cancer, particularly those with a “poor prognosis.” The goal is to provide patients with treatments that are easier to tolerate and with the hope of a longer life.

Our targets are cancers that are particularly difficult to treat with the current therapeutic arsenal, and which are behind a large number of deaths every year in Canada, including:

Castration-resistant prostate cancer

4900
DEATHS¹

Triple-negative breast cancer

5400
DEATHS¹

Pancreatic cancer

5900
DEATHS¹

Lung cancer

20600
DEATHS¹

Colorectal cancer

9300
DEATHS¹

¹ Estimated number of deaths in Canada in 2023 (Canadian Cancer Society).

WHO WE ARE

A far-sighted company

Neolys Pharma is a young Canadian company founded in Quebec City in 2023 by Christian Roby (Pharmacist, B.Pharm.), Donald Poirier (Chemist, Ph.D.), and Dr. René Maltais (Chemist, Ph.D.).

Our team